Therapy: Nonhormonal treatment of hot flashesa viable alternative?

Nature Reviews Endocrinology

Volumn 6, Issue 2, 2010, Pages 66-67

  Nachtigall, Lila E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FLUOXETINE; GABAPENTIN; PAROXETINE; PLACEBO; SERTRALINE; TAMOXIFEN; VENLAFAXINE;

BREAST CANCER; CANCER SURVIVAL; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; SHORT SURVEY;

ADRENERGIC UPTAKE INHIBITORS; AMINES; ANTIDEPRESSIVE AGENTS; BREAST NEOPLASMS; CYCLOHEXANECARBOXYLIC ACIDS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; MENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; TAMOXIFEN;

EID: 76149126127     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.269     Document Type: Short Survey

References (9)

1. Loprinzi, C. L. et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J. Clin. Oncol. 16, 2377-2381 (1998).
2. Loprinzi, C. L. et al. venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356, 2059-2063 (2000).
3. Guttuso, T. J. Jr. Gabapentin's effects on hot flashes and hypothermia. Neurology 54, 2161-2163 (2000).
4. Loprinzi, C. L. et al. newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J. Clin. Oncol. 27, 2831-2837 (2009).
5. Loprinzi, C. L., Diekmann, B., novotny, P. J., stearns, v. & sloan, J. A. newer antidepressants and gabapentin for hot flashes: a discussion of trial duration. Menopause 16, 883-887 (2009).
6. Genazzani, A. B. et al. endocrinology of menopausal transition and its brain implications. CNS Spectr. 10, 449-457 (2005).
7. stearns, v. et al. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J. Natl Cancer Inst. 95, 1758-1764 (2003).
8. Goetz, M. P. et al. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J. Clin. Oncol. 23, 9312-9318 (2005).
9. sturdee, D. w. The menopausal hot flash- anything new? Maturitas 60, 42-49 (2008).